Sanofi is continuing its drive to diversify and upgrade its pharmaceuticals portfolio through acquisitions. In its latest move, the French drugmaker said it has signed a...
Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma...
A new CDMO known as Ten23 Health has been launched in Basel, Switzerland. The company that takes its name from Avogadro’s number, a proportion that relates molar mass on...
The question of what kind of particulate matter found its way into vials of Moderna’s Covid-19 vaccine deployed in Japan may have been resolved. There is as yet...
French drugmaker Sanofi may reconsider plans to acquire Translate Bio at the conditions recently announced, the US biotech said in a filing with the US Securities and...
US biotech Moderna announced on Aug. 26 that it had completed its filing with the US Food and Drug Administration (FDA) for full marketing approval of its mRNA-based...
First to receive US approval under an Emergency Use Authorization (EUA) in late 2020, the BioNTech/Pfizer Covid-19 vaccine on Aug. 23 became the first to be fully...
US biotech Novavax, in the final stage of developing its protein-based Covid-19 vaccine, NVX-CoV2373, is adding muscle in human resources before applying to the US Food...
CV2Cov, the next-generation Covid-19 vaccine under development by German biotech CureVac and UK drugs giant GSK, outperformed CureVac’s first-generation Covid shot in...
